|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
SCIDIR_ocn646759162 |
003 |
OCoLC |
005 |
20231117033257.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
081218s2001 caua ob 001 0 eng d |
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCQ
|d UBY
|d OCLCQ
|d OPELS
|d OCLCQ
|d OCLCF
|d OCLCQ
|d DEBBG
|d D6H
|d LEAUB
|d SFB
|d OCLCO
|d OCLCQ
|d OCLCO
|d INARC
|
019 |
|
|
|a 505068867
|a 1127147565
|a 1153813443
|a 1162071285
|
020 |
|
|
|a 0122608275
|q (electronic bk.)
|
020 |
|
|
|a 9780122608278
|q (electronic bk.)
|
020 |
|
|
|a 1281742589
|
020 |
|
|
|a 9781281742582
|
020 |
|
|
|a 9786611742584
|
020 |
|
|
|a 6611742581
|
020 |
|
|
|a 0080861229
|
020 |
|
|
|a 9780080861227
|
035 |
|
|
|a (OCoLC)646759162
|z (OCoLC)505068867
|z (OCoLC)1127147565
|z (OCoLC)1153813443
|z (OCoLC)1162071285
|
050 |
|
4 |
|a RS189
|b .A5827 2001eb
|
082 |
0 |
4 |
|a 615.1/9
|2 23
|
245 |
0 |
0 |
|a Analytical profiles of drug substances.
|n Volume 27 /
|c edited by Harry G. Brittain.
|
260 |
|
|
|a San Diego :
|b Academic Press,
|c �2001.
|
300 |
|
|
|a 1 online resource ([xi], 388 pages) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Analytical profiles of drug substances ;
|v v. 27
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
520 |
|
|
|a Although the official compendia define a drug substance as to identity, purity, strength, and quality, they normally do not provide other physical or chemical data, nor do they list methods of synthesis or pathways of physical or biological degradation and metabolism. Such information is scattered throughout the scientific literature and the files of pharmaceutical laboratories. Edited by the Associate Director of Analytical Research and Development for the American Association of Pharmaceutical Scientists, Analytical Profiles of Drug Substances and Excipients brings this information together in one source. The scope of the series has recently been expanded to include profiles of excipient materials.
|
505 |
0 |
|
|a Front Cover; Analytical Profiles of Drug Substances and Excipients; Copyright Page; Contents; Affiliations of Editors and Contributors; Preface; Chapter 1. Arginine; Chapter 2. Fenoterol Hydrobromide; Chapter 3. Fluconazole; Chapter 4. Flutamide; Chapter 5. Histamine; Chapter 6. Ibuprofen; Chapter 7. Ondansetron Hydrochloride; Chapter 8. Sildenafil Citrate; Chapter 9. Correction: Dorzolamide Hydrochloride; Chapter 10. Correction: Mesalamine; Cumulative Index
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Drugs
|x Analysis.
|
650 |
|
0 |
|a Pharmaceutical chemistry.
|
650 |
|
2 |
|a Chemistry, Pharmaceutical
|0 (DNLM)D002626
|
650 |
|
6 |
|a M�edicaments
|x Analyse.
|0 (CaQQLa)201-0036381
|
650 |
|
6 |
|a Chimie pharmaceutique.
|0 (CaQQLa)201-0028674
|
650 |
|
7 |
|a Drugs
|x Analysis
|2 fast
|0 (OCoLC)fst00898769
|
650 |
|
7 |
|a Pharmaceutical chemistry
|2 fast
|0 (OCoLC)fst01060115
|
655 |
|
4 |
|a Electronic books.
|
700 |
1 |
|
|a Brittain, H. G.
|
710 |
2 |
|
|a Academy of Pharmaceutical Sciences.
|b Pharmaceutical Analysis and Control Section.
|
776 |
0 |
|
|z 0122608275
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780122608278
|z Texto completo
|